AlphaGrep UK’s Incyte INCY Stock Holding History

AlphaGrep UK’s Portfolio INCY Stock Details INCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-4,295	Closed	-$487K	–	862
2026 Q2	$487K	Sell	4,295 -3,959	-48%	-$393K	0.14%	251
2026 Q1	$777K	Buy	8,254 +5,515	+201%	+$550K	0.22%	81
2025 Q4	$271K	Buy	+2,739	New	+$265K	0.09%	485

Other funds holding INCY

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Dodge & Cox San Francisco, California $187B AUM 13.73% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

AlphaGrep UK's INCY Position: Q3 2026 in Review

AlphaGrep UK sold out of Incyte (INCY) in Q3 2026, closing a stake of 4,295 shares — an estimated $487K sold.

AlphaGrep UK first reported a position in INCY in Q4 2025 and held it in 3 quarters. The position peaked at $777K in Q1 2026. 758 funds tracked by Wall St. Rank hold INCY as of Q3 2026.

AlphaGrep UK reported no remaining Incyte position as of Q3 2026 after selling out during the quarter.
AlphaGrep UK sold 4,295 Incyte shares in Q3 2026, an estimated $487K.
AlphaGrep UK first reported a position in Incyte in Q4 2025 and held it in 3 quarters.
AlphaGrep UK's Incyte position peaked at $777K in Q1 2026.
758 funds tracked by Wall St. Rank held Incyte as of Q3 2026.

Based on AlphaGrep UK's 13F filing for Q3 2026, filed 12 Nov 2026.